| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Design Therapeutics, Inc. | Chief Medical Officer | Stock option (right to buy) | 250,000 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DSGN | Design Therapeutics, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Chief Medical Officer | 05 Jan 2026, 16:14 |
| DSGN | Design Therapeutics, Inc. | 01 May 2025 | 1 | $0 | 4 | Chief Medical Officer | 23 May 2025, 16:26 |
| DSGN | Design Therapeutics, Inc. | 16 Apr 2025 | 0 | $0 | 3 | Chief Medical Officer | 23 May 2025, 16:24 |